Qube Research & Technologies (QRT)
BLPH

Qube Research & Technologies (QRT)’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-52
Closed -$21 – 4942
2023
Q3 		$21 Buy
+52
New +$26 ﹤0.01% 3882

Other funds holding BLPH

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BLPH Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 52 shares — an estimated $21 sold.

Qube Research & Technologies (QRT) first reported a position in BLPH in Q3 2023 and held it in 1 quarter. The position peaked at $21 in Q3 2023. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 52 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $21.
  • Qube Research & Technologies (QRT) first reported a position in Bellerophon Therapeutics, Inc. in Q3 2023 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Bellerophon Therapeutics, Inc. position peaked at $21 in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.